Works by Adamopoulos, Ioannis

Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Real-World data for the Treatment of Relapsed/Refractory Multiple Myeloma with Lenalidomide and Dexamethasone in 2nd Line (Legend Study): The Prognostic Significance of Biochemical Versus Clinical Relapse.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e130, doi. 10.1016/j.clml.2017.03.236
    By:
    • Katodritou, Eirini;
    • Delimpasi, Sossana;
    • Kyrtsonis, Marie Christine;
    • Kyriakou, Despoina;
    • Symeonidis, Argiris;
    • Spanoudakis, Emmanouil;
    • Vassilopoulos, Georgios;
    • Anagnostopoulos, Achilles;
    • Kioumi, Anna;
    • Zikos, Panagiotis;
    • Aktypi, Anthi;
    • Mpriasoulis, Evangelos;
    • Megalakaki, Aikaterini;
    • Kotsopoulou, Maria;
    • Repousis, Panagiotis;
    • Adamopoulos, Ioannis;
    • Gogos, Dimitrios;
    • Papa, Vassiliki;
    • Papadaki, Helen;
    • Terpos, Evangelos
    Publication type:
    Article
    12
    13

    National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.

    Published in:
    Annals of Hematology, 2019, v. 98, n. 1, p. 55, doi. 10.1007/s00277-018-3493-4
    By:
    • on behalf of the Greek Haemoglobinopathies Study Group;
    • Greek Haemoglobinopathies Study Group;
    • Voskaridou, Ersi;
    • Maragkos, Konstantinos;
    • Petropoulou, Fotini;
    • Eftihiadis, Eftihios;
    • Klironomos, Evangelos;
    • Koutsouka, Freideriki;
    • Nestora, Konstantina;
    • Tzoumari, Ioanna;
    • Papageorgiou, Ourania;
    • Basileiadi, Artemis;
    • Lafiatis, Ioannis;
    • Kattamis, Antonis;
    • Dimitriadou, Efthimia;
    • Kalpaka, Anastasia;
    • Kalkana, Chrysoula;
    • Xanthopoulidis, Georgios;
    • Adamopoulos, Ioannis;
    • Kaiafas, Panagiotis
    Publication type:
    Article
    14

    Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

    Published in:
    2018
    By:
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Delimpasi, Sosana;
    • Kyriakou, Despoina;
    • Symeonidis, Argiris;
    • Spanoudakis, Emmanouil;
    • Vasilopoulos, Georgios;
    • Anagnostopoulos, Achilles;
    • Kioumi, Anna;
    • Zikos, Panagiotis;
    • Aktypi, Anthi;
    • Briasoulis, Evangelos;
    • Megalakaki, Aikaterini;
    • Repousis, Panayiotis;
    • Adamopoulos, Ioannis;
    • Gogos, Dimitrios;
    • Kotsopoulou, Maria;
    • Pappa, Vassiliki;
    • Papadaki, Eleni;
    • Fotiou, Despoina
    Publication type:
    journal article
    15

    Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

    Published in:
    2018
    By:
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Delimpasi, Sosana;
    • Kyriakou, Despoina;
    • Symeonidis, Argiris;
    • Spanoudakis, Emmanouil;
    • Vasilopoulos, Georgios;
    • Anagnostopoulos, Achilles;
    • Kioumi, Anna;
    • Zikos, Panagiotis;
    • Aktypi, Anthi;
    • Briasoulis, Evangelos;
    • Megalakaki, Aikaterini;
    • Repousis, Panayiotis;
    • Adamopoulos, Ioannis;
    • Gogos, Dimitrios;
    • Kotsopoulou, Maria;
    • Pappa, Vassiliki;
    • Papadaki, Eleni;
    • Fotiou, Despoina
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21
    22
    23